Research reveals new insights into a key antibiotic target in the fight against TB

Research reveals new insights into a key antibiotic target in the fight against TB
Full Mycobacterium tuberculosis infection (Pulmonary Tuberculosis) Credit: stockdevil

Scientists at the University of Sussex have unraveled a key process in the bacterium that causes tuberculosis (TB), potentially paving the way for new antibiotics to fight the disease. 

TB is one of the world's top infectious killers, causing 1.5 million deaths every year. The TB bacterium Mycobacterium (Mtb) is estimated to be present in up to a third of the world's population, although active TB only develops in around one in 10 cases. 

While TB is curable, is on the rise and so a major challenge for scientists is to continually develop to treat the disease. 

Now an international effort involving scientists at Sussex and the Rockefeller University in New York has revealed that the key process in Mtb cells of reading the information contained in DNA differs from that in most other bacteria. Their findings are published in the journal Proceedings of the National Academy of Sciences

The process is called transcription and is conducted by an enzyme, called RNA polymerase, which uses a protein called sigma to bind with parts of the DNA. 

But researchers have now observed for the first time how, in Mtb, a second protein, called RbpA, helps in this process by binding to different parts of the DNA. 

Lead researcher, Dr Mark Paget, said: "Up until recently, we've always thought that RNA polymerase, whether it's in one bacterium or another, is pretty much identical. We now know that Mtb uses this additional protein and exactly what role it plays in transcription". 

RNA polymerase is one of the few proven targets for antibiotics in this organism, so this new finding should help in the testing of potential new drugs that inhibit RNA polymerase under laboratory conditions. This speeds up the drug discovery process by allowing scientists to quickly rule out treatments that do not work. 

More information: "Structural, functional, and genetic analyses of the actinobacterial transcription factor RbpA" PNAS 2015 112 (23) 7171-7176; published ahead of print May 26, 2015, DOI: 10.1073/pnas.1504942112

Citation: Research reveals new insights into a key antibiotic target in the fight against TB (2015, June 30) retrieved 27 March 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Tuberculosis avoids and subverts host immunity


Feedback to editors